Berenberg Bank Analysts Give Gerresheimer AG (GXI) a €75.00 Price Target

Gerresheimer AG (ETR:GXI) has been given a €75.00 ($88.24) price target by stock analysts at Berenberg Bank in a note issued to investors on Wednesday. The brokerage currently has a “buy” rating on the stock.

A number of other brokerages have also recently weighed in on GXI. Deutsche Bank AG set a €62.00 ($72.94) price target on shares of Gerresheimer AG and gave the stock a “neutral” rating in a research note on Tuesday, September 5th. J P Morgan Chase & Co set a €99.40 ($116.94) price target on shares of Gerresheimer AG and gave the stock a “buy” rating in a research note on Thursday, August 31st. Independent Research GmbH set a €78.00 ($91.76) price target on shares of Gerresheimer AG and gave the stock a “neutral” rating in a research note on Wednesday, July 19th. DZ Bank AG reiterated a “buy” rating on shares of Gerresheimer AG in a research note on Monday, July 17th. Finally, Hauck & Aufhaeuser set a €80.00 ($94.12) price target on shares of Gerresheimer AG and gave the stock a “neutral” rating in a research note on Friday, July 14th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and five have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of €72.94 ($85.81).

Gerresheimer AG (GXI) opened at 65.99 on Wednesday. The company’s 50 day moving average is €65.42 and its 200 day moving average is €70.49. The stock has a market cap of €2.07 billion and a PE ratio of 18.28. Gerresheimer AG has a one year low of €59.97 and a one year high of €79.47.

ILLEGAL ACTIVITY NOTICE: This piece was posted by Markets Daily and is the sole property of of Markets Daily. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of international trademark and copyright laws. The original version of this piece can be viewed at https://www.themarketsdaily.com/2017/10/11/berenberg-bank-analysts-give-gerresheimer-ag-gxi-a-75-00-price-target.html.

About Gerresheimer AG

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer AG (ETR:GXI)

Receive News & Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply